摘要
目的：：研究分析美洛培南与左氧氟沙星治疗老年重症吸入性肺炎的临床效果.方法：择取2013．09－2014．09期间在我院接受药物治疗的68例重症吸入性肺炎的老年患者，将其以1∶1比例随机性分成对照组(应用左氧氟沙星进行治疗)与研究组(应用美洛培南进行治疗)，每组各有34例患者.结果：研究组患者的细菌清除率约为92．31％显著高于对照组的73．68％；临床总有效率约为91．18％(31/34)显著高于对照组的82．35％(28/34)，差异P＜0．05有统计学意义.结论：应用美洛培南治疗老年重症吸入性肺炎的疗效更佳，安全性较好，适用于临床应用、推广.
Abstract
Objective:To study the clinical analysis of the ef ect of meropenem and levofloxacin in the treatment of elderly patients with severe inhalation pneumonia.Methods:68 cases of severe selected elderly patients during 2013.09-2014.09 received drug therapy in our hospital of aspiration pneumonia,its proportion to 1:1 randomly divided into control group(Application of levofloxacin treatment)and study group(Application of meropenem therapy),each group has 34 patients.Result:The study group patients with bacterial clearance rate of about 92.31% was significantly higher than that in control group 73.68%;the total clinical ef iciency is about 91.18%(31/34)was significantly higher than that in control group 82.35%(28/34),the dif erence was statistical y significant P<0.05.Conclusion:The curative ef ect is better application of meropenem in the treatment of aged patients with severe aspiration pneumonia,safety is good,suitable for clinical application and promotion.
NETL
NSTL
万方数据